Revolution Medicines Inc
RVMD
Market Cap$7.53B
Close$
$2.43
93.9% downside
Current Fair Value
93.9% downsideOvervalued by 93.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.53 Billion |
|---|---|
| Enterprise Value | $7.12 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.58 |
| Beta | 1.12 |
| Outstanding Shares | 173,758,250 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -11.7 |
|---|---|
| PEG | -26.52 |
| Price to Sales | - |
| Price to Book Ratio | 3.07 |
| Enterprise Value to Revenue | 9598.02 |
| Enterprise Value to EBIT | -10.86 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Revolution Medicines Inc
CEO: Mark Goldsmith